MEDITERRANEAN NUTRITION SCIENCE
LIVE

Serial Number

79418152

Owner

Esserre Pharma Srl

Attorney

Larry H. Tronco

Filing Date

Nov 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MEDITERRANEAN NUTRITION SCIENCE Trademark

Serial Number: 79418152 • Registration: 8268411

MEDITERRANEAN NUTRITION SCIENCE is a trademark filed by Esserre Pharma Srl on November 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Esserre Pharma Srl

Via Flaminia Nuova, 260

Entity Type: 99

Trademark Details

Filing Date

November 8, 2023

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceutical preparations and natural medicines in nature of medicinal herbal preparations for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergies, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headaches, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, and tissue trauma; Food supplements and dietary preparations, namely, dietary supplements for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergies, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headaches, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, and tissue trauma; Pharmaceutical skin lotions; Dermatological pharmaceutical products

Pharmaceutical research services; Pharmaceutical and drug product development; Pharmaceutical research and development; Conducting clinical studies in the nature of scientific clinical trial research for others in the field of pharmaceutical products; Pharmaceutical research and development consultancy; Technical consultancy in relation to research services relating to food and dietary supplements

Educational services, namely, providing seminars and online courses of instruction in the field of health and nutrition; Book publishing and editing services; Organization of conferences and exhibitions in the field of health and nutrition for educational purposes; rental of audiovisual equipment and performing arts facilities for the production of educational events

Chemical and organic compositions, namely, antioxidants, cellobiose, and allulose for use in the manufacture of food and beverages; Chemical additives in the nature of chemical substances, chemical materials and preparations, and natural elements for use in the manufacture of pharmaceutical products, food supplements and cosmetics; Chemical compounds and materials for use in science, namely, reagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Active chemical ingredients for use in the manufacture of pharmaceuticals; Plant extracts, other than essential oils, for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; Chemical additives for use in the manufacture of food supplements; Plant extracts, other than essential oils, for use in the manufacture of food supplements; Plant extracts, other than essential oils, for use in the food industry, namely, plant extracts in the manufacture of foods; Plant extracts, other than essential oils, for use in the manufacture of cosmetics; Botanical extracts, other than essential oils, for the manufacture of cosmetics

Cosmetic preparations; Perfume oils for the manufacture of cosmetic preparations; Essential oils and aromatic extracts being aromatic essential oils; Cleansing and perfuming preparations being perfume oils; cosmetic body care preparations and beauty care preparations in the nature of beauty care cosmetics; perfumery and fragrances; cosmetic oils; cosmetics and cosmetic preparations; toiletries namely, non-medicated toiletry preparations

Dietary and nutritional advice in the form of guidance; Provision of health information in the field of dietary and nutritional supplements; Provision of health information relating to dietary and nutritional guidance; Medical assistance

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 13, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 26, 2026 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2026 ADCH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Apr 2, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 18, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 13, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jun 11, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jun 7, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 2, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 21, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 27, 2025 REPR